Back

Exploring the role of novel CETP inhibitors in lipid management

27 August 2023 (10:45 - 10:55)
Organised by: Logo
Congress Presentation Part of: Role of CETP inhibitors in cardiovascular risk reduction: will lessons from the past lead to future success? Lipid-Lowering Agents Open Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York City (United States of America)

4 More presentations in this session

Presentation thumbnail
Introduction
Professor E. Stroes (Amsterdam, NL)
Slides Video
Presentation thumbnail
Unmet needs in lowering LDL-c: barriers to goal attainment and need for innovative targets
Professor S. Nicholls (Melbourne, AU)
Slides Video
Presentation thumbnail
New insights on CETP inhibitors from genetic research and clinical trials
Professor J. Kastelein (Amsterdam, NL)
Slides Video
Presentation thumbnail
Discussion
Professor E. Stroes (Amsterdam, NL) Professor S. Nicholls (Melbourne, AU) Professor J. Kastelein (Amsterdam, NL) Professor R. Mehran (New York City, US)
Video

Access the full session

Session thumbnail
Role of CETP inhibitors in cardiovascular risk reduction: will lessons from the past lead to future success?
Video

The Event

Event poster

ESC Congress 2023

27 August 2023 10:45 CET
You may be interested in
thumbnail
Congress Presentation
A novel CETP-inhibitor to target CV risk reduction: where could it fit in future lipid management?
thumbnail
Congress Presentation
Novel oral pathways in LDL-c lowering therapy: the new promise of oral CETP inhibitors
thumbnail
Congress Presentation
Novel oral LDL-c lowering therapies on the horizon: CETP inhibition

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources